Latest News in the pharma Industry

Market News

Sanner acquisition strengthens company's leadership in effervescent packaging market

Sanner acquisition strengthens company's leadership in effervescent packaging market

30 May 2017

Acquisition of Jaco enables Sanner to operate as a system supplier.

Read more 
Orchard Therapeutics signs manufacturing services agreement with PCT Cell Therapy Services

Orchard Therapeutics signs manufacturing services agreement with PCT Cell Therapy Services

30 May 2017

Under the terms of this new agreement, PCT will provide GMP-compliant manufacturing services for Orchard’s lead product, OTL-101, an autologous ex-vivo gene therapy for the treatment of ADA-SCID.

Read more 
Recipharm makes strategic appointment in the UK & Ireland

Recipharm makes strategic appointment in the UK & Ireland

30 May 2017

Shabbir Mostafa to join the CDMO as Director, Business Management, with responsibility for driving sales of Recipharm’s manufacturing services.

Read more 
Lupin Pharmaceuticals announces nationwide recall of Mibelas 24 Fe tablets

Lupin Pharmaceuticals announces nationwide recall of Mibelas 24 Fe tablets

30 May 2017

Recall due to out of sequence tablets and missing expiry/lot information.

Read more 
Pharmaceutical case studies illustrating data analytics strategies

Pharmaceutical case studies illustrating data analytics strategies

26 May 2017

New webinar hosted by Xtalks focuses on extracting the most value from data assets.

Read more 
PDA initiative connecting drug manufacturers, glass suppliers to make manufacturing great

PDA initiative connecting drug manufacturers, glass suppliers to make manufacturing great

26 May 2017

First initiative is to eliminate visible particles from parenteral products,

Read more 
Merck strikes deal with Teijin Pharma for investigational antibody candidate targeting tau

Merck strikes deal with Teijin Pharma for investigational antibody candidate targeting tau

25 May 2017

The addition of this antibody targeting tau will complement Merck’s portfolio of candidates being investigated for the treatment of Alzheimer's disease.

Read more 
Hovione starts clinical trial of its proprietary minocycline sterile ointment to treat a subset of anterior ocular inflammation

Hovione starts clinical trial of its proprietary minocycline sterile ointment to treat a subset of anterior ocular inflammation

25 May 2017

First clinical study using a patent protected minocycline API and formulation developed by Hovione.

Read more 
PharmaMar and Eczacıbaşı sign a licensing agreement for Aplidin in Turkey

PharmaMar and Eczacıbaşı sign a licensing agreement for Aplidin in Turkey

25 May 2017

Aplidin is PharmaMar's second most advanced anticancer drug currently under development for the treatment of multiple myeloma and angioimmunoblastic T-cell lymphoma.

Read more 
Bioverativ to acquire clinical-stage rare disease biotechnology company, True North Therapeutics

Bioverativ to acquire clinical-stage rare disease biotechnology company, True North Therapeutics

25 May 2017

Strengthens pipeline with lead candidate TNT009 in cold agglutinin disease, a rare and chronic autoimmune hemolytic anemia with no approved therapies.

Read more 
FDA approves Kevzara for the treatment of moderately to severely active RA in adults

FDA approves Kevzara for the treatment of moderately to severely active RA in adults

23 May 2017

Kevzara is now available to US patients.

Read more 
Thermo Fisher Scientific to acquire Patheon

Thermo Fisher Scientific to acquire Patheon

22 May 2017

Patheon provides entry into the attractive, high-growth CDMO market.

Read more